Patents by Inventor Benjamin SAMELSON-JONES

Benjamin SAMELSON-JONES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230250412
    Abstract: Factor IX/IXa variants and methods of use thereof are disclosed.
    Type: Application
    Filed: March 1, 2023
    Publication date: August 10, 2023
    Inventors: Valder R. Arruda, Rodney M. Camire, Benjamin Samelson-Jones
  • Patent number: 11708570
    Abstract: Factor IX/IXa variants and methods of use thereof are disclosed.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: July 25, 2023
    Assignee: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
    Inventors: Valder R. Arruda, Rodney M. Camire, Benjamin Samelson-Jones
  • Publication number: 20220220188
    Abstract: The invention includes compositions comprising at least one chimeric alloantigen receptor (CALLAR) specific for an alloantibody, vectors comprising the same, compositions comprising CALLAR vectors packaged in viral particles, and recombinant T cells comprising the CALLAR. The invention also includes methods of making a genetically modified T cell expressing a CALLAR, wherein the expressed CALLAR comprises a Factor VIII or fragment thereof extracellular domain.
    Type: Application
    Filed: August 23, 2021
    Publication date: July 14, 2022
    Inventors: Michael C. MILONE, Valder ARRUDA, Sarah RICHMAN, Benjamin SAMELSON-JONES
  • Publication number: 20220033475
    Abstract: Factor VIII variants and methods of use thereof are disclosed.
    Type: Application
    Filed: October 23, 2019
    Publication date: February 3, 2022
    Inventors: Valder R. Arruda, Benjamin Samelson-Jones
  • Publication number: 20200248161
    Abstract: Factor IX/IXa variants and methods of use thereof are disclosed.
    Type: Application
    Filed: July 27, 2017
    Publication date: August 6, 2020
    Inventors: Valder R. Arruda, Rodney M. Camire, Benjamin Samelson-Jones
  • Publication number: 20190153064
    Abstract: The invention includes compositions comprising at least one chimeric alloantigen receptor (CALLAR) specific for an alloantibody, vectors comprising the same, compositions comprising CALLAR vectors packaged in viral particles, and recombinant T cells comprising the CALLAR. The invention also includes methods of making a genetically modified T cell expressing a CALLAR, wherein the expressed CALLAR comprises a Factor VIII or fragment thereof extracellular domain.
    Type: Application
    Filed: April 14, 2017
    Publication date: May 23, 2019
    Inventors: Michael C. MILONE, Valder ARRUDA, Sarah RICHMAN, Benjamin SAMELSON-JONES